| __timestamp | Bausch Health Companies Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 91733000 |
| Thursday, January 1, 2015 | 2682700000 | 87644000 |
| Friday, January 1, 2016 | 2810000000 | 92365000 |
| Sunday, January 1, 2017 | 2582000000 | 85656000 |
| Monday, January 1, 2018 | 2473000000 | 88196000 |
| Tuesday, January 1, 2019 | 2554000000 | 89971000 |
| Wednesday, January 1, 2020 | 2367000000 | 93413000 |
| Friday, January 1, 2021 | 2624000000 | 91355000 |
| Saturday, January 1, 2022 | 2625000000 | 113676000 |
| Sunday, January 1, 2023 | 2917000000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Unlocking the unknown
Over the past decade, the pharmaceutical giants Bausch Health Companies Inc. and Taro Pharmaceutical Industries Ltd. have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. Bausch Health has consistently maintained higher SG&A costs, peaking in 2023 with a 44% increase from 2014. In contrast, Taro Pharmaceutical's SG&A expenses have remained relatively stable, with a notable surge in 2023, marking a 116% rise from 2014. This divergence highlights Bausch's aggressive operational strategies compared to Taro's more conservative approach. The data from 2014 to 2023 reveals a missing entry for Bausch in 2024, suggesting potential strategic shifts or reporting delays. As the pharmaceutical landscape evolves, these trends offer insights into each company's operational priorities and market positioning.
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
CRISPR Therapeutics AG and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Bausch Health Companies Inc. and Xencor, Inc.
Bausch Health Companies Inc. or Evotec SE: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.